Try the first and only Continuous Glucose Monitor (CGM) designed for pets for free

The Adapet CGM system delivers real-time glucose data, enabling you to monitor and manage diabetic patients with greater precision. It is the only CGM designed for pets, ensuring better reliability and greater accuracy.

Recognized Partner

The Adapet Pet Continuous Glucose Monitor (CGM) is designed for the needs of pets.

  • Extended probe delivers accurate readings through skin and fast-growing fur.
  • Custom enzyme formula aligns with pet biochemistry for precision.
  • Wide detection range supports better diagnosis and treatment.
  • Day and night glucose control reduces worry and improves care.

The program has really helped me understand how different foods and activities affect my pet’s glucose levels. Knowing that I can manage this confidently has given me peace of mind and made caring for my pet much easier.

- MyAdapet participant

  • Accurate

    Feel more confident in their diabetes management

  • Easy to use

    Glucose readings are displayed on your smartphone

  • Knowledge

    Have a better understanding of how food impacts their glucose levels

1 of 3

Important Safety Information

Adapet Pet CGM A1: Failure to use Adapet Pet CGM A1 systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a traditional blood glucose meters for treatment decisions.

The product images are for illustrative purposes only.

The Adapet Medical, Adapet Pet CGM A1 and related brand marks are marks of Adapet Medical INC. Other trademarks are the property of their respective owners.

No use of any Adapet Medical INC trademark, trade name, or trade dress in this site may be made without prior written authorization of Adapet Medical INC, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States and Canada.